March 2024 was a brutal stretch for some stocks—supply chain snags, rate hikes, and sector slumps hit hard. Now, on March 5, 2025, we’re spotlighting the top 5 that were drowning back then and checking their pulse today. Plus, a killer book to sharpen your investing game—let’s dive in!
- Intel (INTC)
- March 2024 Struggle: Down ~15% YTD by mid-March (Morningstar), hammered by chip shortages and Nvidia’s shadow.
- March 2025 Update: X says AI bets are lifting it, but it’s still -59% from a year ago (Morningstar, Dec 2024). Undervalued gem or bust?
- Walgreens Boots Alliance (WBA)
- March 2024 Struggle: Crashed ~50% from January highs (Money.com), dragged by healthcare and retail woes.
- March 2025 Update: Up 3.4% in Dec but -61.4% for 2024 (Morningstar). X calls it a 5-star bargain—rebound time?
- Moderna (MRNA)
- March 2024 Struggle: Off ~30% YTD (Forbes), as vaccine demand tanked post-COVID.
- March 2025 Update: Down ~4% this week, -26% YTD (Investopedia). X debates its biotech future—still a long shot.
- Tesla (TSLA)
- March 2024 Struggle: Dropped ~25% YTD (Investopedia), with EV hype fading and Elon’s X antics distracting.
- March 2025 Update: Lost ~5% this month, -22% YTD (Investopedia). X loves the chaos—tariffs add spice.
- First Solar (FSLR)
- March 2024 Struggle: Down ~20% YTD (U.S. News), hurt by solar policy wobbles and costs.
- March 2025 Update: Shed ~5% this week, -27% YTD (Investopedia). X sees tariff pain but renewable hope.
Book Spotlight: The Intelligent Investor by Benjamin Graham
Want to spot flops before they sink? The Intelligent Investor ($16.99 on Amazon) is the OG guide to value investing—Buffett swears by it. From margin of safety to market psychology, it’s your playbook for navigating 2025’s wild ride. Grab it here.
Last year’s losers—some are climbing, some are clinging. Which one’s your bet? Hit the comments with your take!
